New hope: testing a vital vaccine for vulnerable HIV community
NCT ID NCT06576024
Summary
This study tested whether the standard hepatitis A vaccine is safe and works well for people living with HIV, including children as young as 1. About 400 participants received the vaccine, and researchers checked their blood for protective antibodies and monitored for any side effects. The goal was to see if this vaccine provides good protection for people with weakened immune systems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Liuzhou People's Hospital
Liuchow, Guangxi, China
Conditions
Explore the condition pages connected to this study.